The Blue Journal thanks Eckart De Bie, MD, MPhil, for his contribution to the January issue
Inflammation and Obesity Correlate in Pulmonary Hypertension but Associate with Diverging Outcomes
@mark-toshner.bsky.social
academic.oup.com/ajrccm/artic...
18.02.2026 18:51
👍 7
🔁 3
💬 0
📌 0
Has the MRC research funding ‘pause’ been covered by any major news network?
It feels like it should be a major news story
28.01.2026 06:19
👍 28
🔁 11
💬 8
📌 4
Genomic heterogeneity inflates the performance of variant pathogenicity predictions www.biorxiv.org/content/10.1... 🧬🖥️🧪 "we identify the best-performing models for each variant type and establish a benchmark to guide future progress"
09.09.2025 15:55
👍 2
🔁 2
💬 0
📌 0
Seqera Sessions, Cambridge, UK
Join us in Cambridge for a day of hands-on training and expert talks at the intersection of bioinformatics, research, and innovation. Whether you’re new to Nextflow or looking to deepen your expertise...
If you're in Cambridge next week, join us for a day of Nextflow training and featured talks, including from @genomicsengland.bsky.social. Plus, networking with the @seqera.io team, including @evanfloden.bsky.social, co-creator of Nextflow! 👩💻
We hope to see you there! hubs.la/Q03GRlRB0
04.09.2025 08:52
👍 3
🔁 4
💬 0
📌 0
Expressions of Interest OPEN for #BattenDisease Grant Round. The top priority research lines are so inspiring: best gene-targeted #therapy? which valid, reliable #biomarkers? Can disease progression be halted or reversed? Apply here: bdsrafoundation.org/wp-content/u...
21.08.2025 09:11
👍 1
🔁 1
💬 0
📌 0
BDFA Response to NICE Final Draft Guidance not Recommending Cerliponase Alfa for Treating Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) | Batten Disease Family Association (BDFA)
Some kids are apparently too expensive to treat.
The UK’s National Institute for Health and Care Excellence (NICE) decided it will stop recommending the ONLY approved treatment for CLN2 Batten Disease.
They cite a lack of proof of long-term effectiveness and, surprise, cost.
Obscenely cruel.
15.08.2025 04:45
👍 0
🔁 2
💬 0
📌 0
Group Leader - Genome Biology Unit
Are you ready to lead groundbreaking research in Genome Biology? Join us at EMBL! We are seeking a motivated scientist to lead an independent research group addressing exciting and original biological...
To all post-docs: The Genome Biology dept @embl.org
has an Independent faculty position. Fantastic place to set up your lab –great package: core funding, fantastic Ph.D. students, cutting edge core facilities & great colleagues. Closing date Sept 19th
embl.wd103.myworkdayjobs.com/en-US/EMBL/j...
30.07.2025 13:41
👍 192
🔁 225
💬 0
📌 9
I just got the notice that all the FlyBase people at Harvard, including me, will be laid off on October 12. I'm devastated.
11.08.2025 18:12
👍 378
🔁 223
💬 64
📌 50
What do people use for references in Google docs/word? Coming from latex where referencing was solid, have been stung a couple of times by Google docs/zotero losing or messing up which paper each reference number points to. This is too painful to go through again. What are the alternatives?
31.07.2025 08:46
👍 2
🔁 2
💬 4
📌 1
Home - ProbGen 2026
Your Site Description
The 2026 Probabilistic Modeling in Genomics (ProbGen) meeting will be held at UC Berkeley, March 25-28, 2026. We have an amazing list of keynote speakers and session chairs:
probgen2026.github.io
Please help spread the news.
06.06.2025 17:52
👍 69
🔁 36
💬 2
📌 0
Five days without access to the HPC. What does one do? Wrong answers only pls
#bioinformatics
#hpc
21.07.2025 08:47
👍 1
🔁 0
💬 2
📌 0
I really like following how to build your own workflow, and then integrate to an existing workflow by adding neat features in #nextflow pipeline youtu.be/w3bOiBUdR_g
11.06.2025 10:34
👍 1
🔁 0
💬 0
📌 0